Kevin C Mccallum, MD | |
1185 W Carmel Dr Ste D1a, Carmel, IN 46032-8708 | |
(317) 669-2248 | |
Not Available |
Full Name | Kevin C Mccallum |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 31 Years |
Location | 1185 W Carmel Dr Ste D1a, Carmel, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164490389 | NPI | - | NPPES |
200094780 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 01042595A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Indiana University Health North Hospital | Carmel, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Vincent Medical Group Inc | 7012047640 | 625 |
News Archive
A world-first completed clinical study by an Australian team has found Kava, a medicinal South Pacific plant, significantly reduced the symptoms of people suffering anxiety.
According to a new report last Thursday, measles incidence is on the rise in Europe following decades of decline. Up to October European health officials reported more than 26,000 measles cases this year and nine deaths.
A&G Pharmaceutical announced today that it has received $1.2 million in Phase II Small Business Innovation Research (SBIR) funding from the National Cancer Institute (NCI) for the program, "Novel Targeted Therapy for Breast Cancer," focused on the development of a neutralizing therapeutic antibody against a novel cancer-associated protein, GP88.
The combination of a cholesterol-lowering drug, Bezafibrate, and a contraceptive steroid, Medroxyprogesterone Acetate, could be an effective, non-toxic treatment for a range of cancers, researchers at the University of Birmingham have found.
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
› Verified 2 days ago
Entity Name | St Vincent Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
A world-first completed clinical study by an Australian team has found Kava, a medicinal South Pacific plant, significantly reduced the symptoms of people suffering anxiety.
According to a new report last Thursday, measles incidence is on the rise in Europe following decades of decline. Up to October European health officials reported more than 26,000 measles cases this year and nine deaths.
A&G Pharmaceutical announced today that it has received $1.2 million in Phase II Small Business Innovation Research (SBIR) funding from the National Cancer Institute (NCI) for the program, "Novel Targeted Therapy for Breast Cancer," focused on the development of a neutralizing therapeutic antibody against a novel cancer-associated protein, GP88.
The combination of a cholesterol-lowering drug, Bezafibrate, and a contraceptive steroid, Medroxyprogesterone Acetate, could be an effective, non-toxic treatment for a range of cancers, researchers at the University of Birmingham have found.
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Kevin C Mccallum, MD 1185 W Carmel Dr Ste D1a, Carmel, IN 46032-8708 Ph: () - | Kevin C Mccallum, MD 1185 W Carmel Dr Ste D1a, Carmel, IN 46032-8708 Ph: (317) 669-2248 |
News Archive
A world-first completed clinical study by an Australian team has found Kava, a medicinal South Pacific plant, significantly reduced the symptoms of people suffering anxiety.
According to a new report last Thursday, measles incidence is on the rise in Europe following decades of decline. Up to October European health officials reported more than 26,000 measles cases this year and nine deaths.
A&G Pharmaceutical announced today that it has received $1.2 million in Phase II Small Business Innovation Research (SBIR) funding from the National Cancer Institute (NCI) for the program, "Novel Targeted Therapy for Breast Cancer," focused on the development of a neutralizing therapeutic antibody against a novel cancer-associated protein, GP88.
The combination of a cholesterol-lowering drug, Bezafibrate, and a contraceptive steroid, Medroxyprogesterone Acetate, could be an effective, non-toxic treatment for a range of cancers, researchers at the University of Birmingham have found.
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
› Verified 2 days ago
Dr. Shelagh Anne Fraser, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 12174 N Meridian St Ste 300, Carmel, IN 46032 Phone: 317-688-9000 Fax: 317-680-9900 | |
Shania Grace Mayer, PA-C Internal Medicine Medicare: Medicare Enrolled Practice Location: 10300 N Illinois St Ste 1100, Carmel, IN 46290 Phone: 317-944-0980 | |
Robert Mark Kinn, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13806 Stone Dr, Carmel, IN 46032 Phone: 317-893-1900 | |
Olivia Ann Fondoble, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13430 N Meridian St Ste 280, Carmel, IN 46032 Phone: 317-582-8030 | |
Dr. Peter Jerome Bustamante, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13450 N Meridian St Ste 354, Carmel, IN 46032 Phone: 317-338-5100 | |
Thomas L Hutchinson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 11725 Illinois Street, Suite 465, Carmel, IN 46032 Phone: 317-817-0010 Fax: 317-817-0012 | |
Chintan J Amin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11725 Illinois St Ste 325, Carmel, IN 46032 Phone: 317-688-5800 Fax: 317-688-5805 |